A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men

Journal of the American Academy of Dermatology

Volumn 47, Issue 3, 2002, Pages 377-385

  Olsen, Elise A ^a   Dunlap, Frank E ^b   Funicella, Toni ^c   Koperski, Judith A ^d   Swinehart, James M ^e   Tschen, Eduardo H ^f   Trancik, Ronald J ^g  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Argus Research Inc   (United States)

^c Pharmaco Health Research Center   (United States)

^d Dermatologist Medical Group of North County   (United States)

^e Colorado Medical Research Center ^*  (United States)

^f Academic Dermatology Associates   (United States)

^g PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOXIDIL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HAIR GROWTH; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; MULTICENTER STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION;

EID: 0036737739     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.124088     Document Type: Article

References (10)

1. Olsen EA. Androgenetic alopecia. In: Olsen EA, editor. Disorders of hair growth: diagnosis and treatment. New York: McGraw-Hill; 1994. p. 257-83.
2. Price VH. Treatment of hair loss. N Engl J Med 1999;341:964-73.
3. Spindler JR. The safety of topical minoxidil solution in the treatment of pattern baldness: the results of a 27-center trial. Clin Dermatol 1988;16:200-12.
4. Rogaine® Extra Strength for Men (5% minoxidil topical solution) for nonprescription use. Summary volume. Kalamazoo (MI): Pharmacia Corporation; 1997.
5. Trancik RJ, Savin RC. Classification scale for male and female androgenetic alopecia [abstract]. Clin Pharmacol Ther 1996;59: 166.
6. Canfield D. Photographic documentation of hair growth in androgenetic alopecia. Dermatol Clin 1999;17:261-9.
7. Ferry JJ, Turner SW, Albert DG, Dietz AJ, Luderer JR. Hemodynamic effects of minoxidil following intravenous infusions in untreated hypertensive patients [abstract]. Clin Pharmacol Ther 1996;59:166.
8. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol 1999;41:717-21.
9. Abell E. Histologic response to topically applied minoxidil in male-pattern alopecia. Clin Dermatol 1988;6:191-4.
10. Headington JT, Novak E. Clinical and histologic studies of male pattern baldness treated with topical minoxidil. Curr Ther Res 1984;36:1098-106.